Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albertus N van Geel

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Annals of Surgical Oncology|August 13, 2009
Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrenceCarmen C van der Pol, Albertus N van Geel, Marian B E Menke-Pluymers, et al.
The Annals of Thoracic Surgery|September 28, 2010
Sternal resection for sarcoma, recurrent breast cancer, and radiation-induced necrosisLinetta B Koppert, Albertus N van Geel, Titia E Lans, et al.
Annals of Surgical Oncology|September 1, 2011
20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose mattersJan P Deroose, Alexander M M Eggermont, Albertus N van Geel, et al.
Current Treatment Options in Oncology|December 11, 2007
Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcomaCornelis Verhoef, Johannes H W de Wilt, Dirk J Grünhagen, et al.
Journal of Surgical Oncology|August 23, 2011
Local and intralesional therapy of in-transit melanoma metastasesAlessandro Testori, Mark B Faries, John F Thompson, et al.
Annals of Surgical Oncology|June 22, 2005
Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failureDirk J Grünhagen, Boudewijn van Etten, Flavia Brunstein, et al.
Annals of Surgical Oncology|November 5, 2010
Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients?Jan P Deroose, Jacobus W A Burger, Albertus N van Geel, et al.
Anti-Cancer Drugs|June 6, 2008
Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysisAmir Mearadji, Michael A den Bakker, Albertus N van Geel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2011
Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomasJan P Deroose, Alexander M M Eggermont, Albertus N van Geel, et al.
Urology|July 28, 2007
Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literatureAlbertus N van Geel, Michael A den Bakker, Wim Kirkels, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Annals of Surgical Oncology|August 13, 2009
Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrenceCarmen C van der Pol, Albertus N van Geel, Marian B E Menke-Pluymers, et al.
The Annals of Thoracic Surgery|September 28, 2010
Sternal resection for sarcoma, recurrent breast cancer, and radiation-induced necrosisLinetta B Koppert, Albertus N van Geel, Titia E Lans, et al.
Annals of Surgical Oncology|September 1, 2011
20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose mattersJan P Deroose, Alexander M M Eggermont, Albertus N van Geel, et al.
Current Treatment Options in Oncology|December 11, 2007
Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcomaCornelis Verhoef, Johannes H W de Wilt, Dirk J Grünhagen, et al.
Journal of Surgical Oncology|August 23, 2011
Local and intralesional therapy of in-transit melanoma metastasesAlessandro Testori, Mark B Faries, John F Thompson, et al.
Annals of Surgical Oncology|June 22, 2005
Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failureDirk J Grünhagen, Boudewijn van Etten, Flavia Brunstein, et al.
Annals of Surgical Oncology|November 5, 2010
Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients?Jan P Deroose, Jacobus W A Burger, Albertus N van Geel, et al.
Anti-Cancer Drugs|June 6, 2008
Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysisAmir Mearadji, Michael A den Bakker, Albertus N van Geel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2011
Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomasJan P Deroose, Alexander M M Eggermont, Albertus N van Geel, et al.
Urology|July 28, 2007
Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literatureAlbertus N van Geel, Michael A den Bakker, Wim Kirkels, et al.
Pageof 4